Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR) is an immuno-oncology company dedicated to the discovery and development of novel and innovative cancer therapies.


Thumb Date Download
Apr 18, 2016 AACR 2016 Presentation 771 KB
Apr 14, 2016 Q2 2016 Corporate Presentation 2.58 MB
Jan 27, 2016 Bromodomain Inhibitor FV-281 546 KB
Jan 27, 2016 Fluorinov Lead Programs 1.21 MB


Email Address: *
First Name:
Mailing Lists

Enter the code shown above.

Powered By Q4 Web Systems